Redox Regulation of Nrf2 in Cisplatin-Induced Kidney Injury

Overview

Journal Antioxidants (Basel)

Date 2023 Sep 28

PMID 37760031

Authors

Kranti A Mapuskar

Casey F Pulliam

Diana Zepeda-Orozco

Benjamin R Griffin

Muhammad Furqan

Douglas R Spitz

Bryan G Allen

Affiliations

Soon will be listed here.

Abstract

Cisplatin, a potent chemotherapeutic agent, is marred by severe nephrotoxicity that is governed by mechanisms involving oxidative stress, inflammation, and apoptosis pathways. The transcription factor Nrf2, pivotal in cellular defense against oxidative stress and inflammation, is the master regulator of the antioxidant response, upregulating antioxidants and cytoprotective genes under oxidative stress. This review discusses the mechanisms underlying chemotherapy-induced kidney injury, focusing on the role of Nrf2 in cancer therapy and its redox regulation in cisplatin-induced kidney injury. We also explore Nrf2's signaling pathways, post-translational modifications, and its involvement in autophagy, as well as examine redox-based strategies for modulating Nrf2 in cisplatin-induced kidney injury while considering the limitations and potential off-target effects of Nrf2 modulation. Understanding the redox regulation of Nrf2 in cisplatin-induced kidney injury holds significant promise for developing novel therapeutic interventions. This knowledge could provide valuable insights into potential strategies for mitigating the nephrotoxicity associated with cisplatin, ultimately enhancing the safety and efficacy of cancer treatment.

Citing Articles

Taxifolin Protects Against 5-Fluorouracil-Induced Cardiotoxicity in Mice Through Mitigating Oxidative Stress, Inflammation, and Apoptosis: Possible Involvement of Sirt1/Nrf2/HO-1 Signaling.

Abukhalil M, Al-Alami Z, Alfwuaires M, Imran M, Aladaileh S, Althunibat O Cardiovasc Toxicol. 2025; 25(3):455-470.

PMID: 39827225 DOI: 10.1007/s12012-025-09962-w.

Dietary Probiotic GKA4, Dead Probiotic GKA4, and Postbiotic GKA4 Improves Cisplatin-Induced AKI by Autophagy and Endoplasmic Reticulum Stress and Organic Ion Transporters.

Lin J, Jiang W, Tsai Y, Lin S, Chen Y, Chen C Nutrients. 2024; 16(20).

PMID: 39458526 PMC: 11510457. DOI: 10.3390/nu16203532.

Renal Health Through Medicine-Food Homology: A Comprehensive Review of Botanical Micronutrients and Their Mechanisms.

Zhao Y, Song J, Feng R, Hu J, Xu H, Ye M Nutrients. 2024; 16(20).

PMID: 39458524 PMC: 11510533. DOI: 10.3390/nu16203530.

Protective effect of luteolin against oxidative stress‑mediated cell injury via enhancing antioxidant systems.

Fernando P, Ko D, Piao M, Kang K, Herath H, Hyun J Mol Med Rep. 2024; 30(1).

PMID: 38757300 PMC: 11129544. DOI: 10.3892/mmr.2024.13244.

NRF2 in kidney physiology and disease.

Bondi C, Hartman H, Tan R Physiol Rep. 2024; 12(5):e15961.

PMID: 38418382 PMC: 10901725. DOI: 10.14814/phy2.15961.

References

Skinner R, Kaplan R, Nathan P . Renal and pulmonary late effects of cancer therapy. Semin Oncol. 2013; 40(6):757-73. DOI: 10.1053/j.seminoncol.2013.09.009. View

Zhang D, Hannink M . Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol. 2003; 23(22):8137-51. PMC: 262403. DOI: 10.1128/MCB.23.22.8137-8151.2003. View

Jung M, Hotter G, Vinas J, Sola A . Cisplatin upregulates mitochondrial nitric oxide synthase and peroxynitrite formation to promote renal injury. Toxicol Appl Pharmacol. 2008; 234(2):236-46. DOI: 10.1016/j.taap.2008.10.014. View

Gumeni S, Papanagnou E, Manola M, Trougakos I . Nrf2 activation induces mitophagy and reverses Parkin/Pink1 knock down-mediated neuronal and muscle degeneration phenotypes. Cell Death Dis. 2021; 12(7):671. PMC: 8254809. DOI: 10.1038/s41419-021-03952-w. View

Hao Q, Xiao X, Zhen J, Feng J, Song C, Jiang B . Resveratrol attenuates acute kidney injury by inhibiting death receptor‑mediated apoptotic pathways in a cisplatin‑induced rat model. Mol Med Rep. 2016; 14(4):3683-9. PMC: 5042758. DOI: 10.3892/mmr.2016.5714. View

Emadi A, Jones R, Brodsky R . Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol. 2009; 6(11):638-47. DOI: 10.1038/nrclinonc.2009.146. View

Wang S, Tsai K, Chou W, Cheng H, Huang Y, Ou H . Quercetin Mitigates Cisplatin-Induced Oxidative Damage and Apoptosis in Cardiomyocytes through Nrf2/HO-1 Signaling Pathway. Am J Chin Med. 2022; 50(5):1281-1298. DOI: 10.1142/S0192415X22500537. View

Eggler A, Small E, Hannink M, Mesecar A . Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1. Biochem J. 2009; 422(1):171-80. PMC: 3865926. DOI: 10.1042/BJ20090471. View

Dewaeles E, Carvalho K, Fellah S, Sim J, Boukrout N, Caillierez R . Istradefylline protects from cisplatin-induced nephrotoxicity and peripheral neuropathy while preserving cisplatin antitumor effects. J Clin Invest. 2022; 132(22). PMC: 9663157. DOI: 10.1172/JCI152924. View

10.

Sihvola V, Levonen A . Keap1 as the redox sensor of the antioxidant response. Arch Biochem Biophys. 2016; 617:94-100. DOI: 10.1016/j.abb.2016.10.010. View

11.

Ramadori G, Cameron S . Effects of systemic chemotherapy on the liver. Ann Hepatol. 2010; 9(2):133-43. View

12.

Yamamoto M, Kensler T, Motohashi H . The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis. Physiol Rev. 2018; 98(3):1169-1203. PMC: 9762786. DOI: 10.1152/physrev.00023.2017. View

13.

Hsu W, Hsiao P, Lin P, Chen S, Lee M, Shin S . Effect of metformin on kidney function in patients with type 2 diabetes mellitus and moderate chronic kidney disease. Oncotarget. 2018; 9(4):5416-5423. PMC: 5797060. DOI: 10.18632/oncotarget.23387. View

14.

Cuadrado A, Rojo A, Wells G, Hayes J, Cousin S, Rumsey W . Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat Rev Drug Discov. 2019; 18(4):295-317. DOI: 10.1038/s41573-018-0008-x. View

15.

Dong X, Chu L, Cao X, Xiong Q, Mao Y, Chen C . Glutathione metabolism rewiring protects renal tubule cells against cisplatin-induced apoptosis and ferroptosis. Redox Rep. 2023; 28(1):2152607. PMC: 9879199. DOI: 10.1080/13510002.2022.2152607. View

16.

Heney D, Wheeldon J, Rushworth P, Chapman C, Lewis I, Bailey C . Progressive renal toxicity due to ifosfamide. Arch Dis Child. 1991; 66(8):966-70. PMC: 1793427. DOI: 10.1136/adc.66.8.966. View

17.

Oh G, Kim H, Shen A, Lee S, Khadka D, Pandit A . Cisplatin-induced Kidney Dysfunction and Perspectives on Improving Treatment Strategies. Electrolyte Blood Press. 2015; 12(2):55-65. PMC: 4297704. DOI: 10.5049/EBP.2014.12.2.55. View

18.

Gunturk I, Yazici C, Kose S, Dagli F, Yucel B, Yay A . The effect of N-acetylcysteine on inflammation and oxidative stress in cisplatin-induced nephrotoxicity: a rat model. Turk J Med Sci. 2019; 49(6):1789-1799. PMC: 7518668. DOI: 10.3906/sag-1903-225. View

19.

Pajares M, Jimenez-Moreno N, Garcia-Yague A, Escoll M, de Ceballos M, Van Leuven F . Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes. Autophagy. 2016; 12(10):1902-1916. PMC: 5079676. DOI: 10.1080/15548627.2016.1208889. View

20.

Soetikno V, Sari S, Ul Maknun L, Sumbung N, Rahmi D, Pandhita B . Pre-Treatment with Curcumin Ameliorates Cisplatin-Induced Kidney Damage by Suppressing Kidney Inflammation and Apoptosis in Rats. Drug Res (Stuttg). 2018; 69(2):75-82. DOI: 10.1055/a-0641-5148. View